0001209191-21-010708.txt : 20210216
0001209191-21-010708.hdr.sgml : 20210216
20210216161533
ACCESSION NUMBER: 0001209191-21-010708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Jolie
CENTRAL INDEX KEY: 0001768223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 21638616
MAIL ADDRESS:
STREET 1: C/O NEON THERAPEUTICS, INC.
STREET 2: 40 ERIE ST., SUITE 110
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-11
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001768223
Siegel Jolie
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Legal Officer
Stock Option (Right to Buy)
45.54
2021-02-11
4
A
0
84850
0.00
A
2031-02-10
Common Stock
84850
84850
D
This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021.
/s/ Jolie M. Siegel
2021-02-16